Details for Patent: 8,992,970
✉ Email this page to a colleague
Which drugs does patent 8,992,970 protect, and when does it expire?
Patent 8,992,970 protects ONIVYDE and is included in one NDA.
This patent has forty-seven patent family members in nineteen countries.
Summary for Patent: 8,992,970
Title: | Liposomes useful for drug delivery |
Abstract: | The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provides methods of making the liposome compositions provided by the present invention. |
Inventor(s): | Hong; Keelung (San Francisco, CA), Drummond; Daryl C. (Pacifica, CA), Kirpotin; Dmitri (San Francisco, CA) |
Assignee: | Merrimack Pharmaceuticals, Inc. (Cambridge, MA) |
Application Number: | 14/175,365 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Compound; Formulation; |
Drugs Protected by US Patent 8,992,970
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipsen | ONIVYDE | irinotecan hydrochloride | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 207793-001 | Oct 22, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,992,970
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005240131 | ⤷ Try a Trial | |||
Canada | 2566007 | ⤷ Try a Trial | |||
Canada | 2821167 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |